The Translational Research Initiative for Hearing (TRIH) grant is international. We fund applied research projects based at research institutes and small-medium enterprises (SMEs) across the world.
The Hearing Medicines Discovery Syndicate has been enabled by a strategic partnership between Action on Hearing Loss and the Medicines Discovery Catapult.
Our Translational Research Initiative for Hearing (TRIH) Partners are organisations that work with us to support the development of treatments for hearing loss and tinnitus.
We are the leading UK hearing loss charity, benefiting from active members and volunteers. We have strong links to people confronting hearing loss and tinnitus, through our local support services, extensive social media networks, popular members' magazine and website.
Before a treatment is made available to the public, it has to be tested in a large group of people to make sure it’s safe and effective. These tests are called clinical trials.
We provide expert advice to pharmaceutical, biotechnology and medical-device companies on the current status of, and opportunities in, the hearing loss and tinnitus therapy areas.
TRIH helps developers get their research to a point where it could attract the commercial funding necessary to take treatments to market. We need your support to invest more, in this promising, life-changing research across the world.